Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2021 September Science Genetic identification of older AML patients achieving long-term survival with intensive chemo... Read more
2021 September Prevention Impaired responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–direct... Read more
2021 September Clinical trials Early, deep and durable responses with ciltacabtagene autoleucel in multiple myeloma Read more
2021 June Editor's pick RELEVANT LITERATURE FOR YOUR DAILY PRACTICE SELECTED BY: JAN VAN DROOGENBROECK Read more
2021 June Clinical practice Outcomes in patients treated with CAR-T therapy who were admitted to intensive care Read more
2021 June Science Intensified treatment for patients with early stage, unfavourable Hodgkin’s lymphoma Read more
Top
